JOURNAL ARTICLE

Cytarabine/daunorubicin

Year: 2022 Journal:   Reactions Weekly Vol: 1926 (1)Pages: 192-192   Publisher: Adis, Springer Healthcare
Keywords:
Daunorubicin Cytarabine Medicine Pharmacology Internal medicine Leukemia

Metrics

0
Cited By
0.00
FWCI (Field Weighted Citation Impact)
1
Refs
0.28
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Topics

Chemotherapy-related skin toxicity
Health Sciences →  Medicine →  Dermatology
Chronic Lymphocytic Leukemia Research
Health Sciences →  Medicine →  Genetics
Fungal Infections and Studies
Health Sciences →  Medicine →  Epidemiology

Related Documents

JOURNAL ARTICLE

Daunorubicin see Cytarabine/daunorubicin

&NA;

Journal:   Reactions Weekly Year: 1991 Vol: &NA; (354)Pages: 8-8
JOURNAL ARTICLE

Cytarabine/cytarabine/daunorubicin/etoposide

Journal:   Reactions Weekly Year: 2022 Vol: 1917 (1)Pages: 201-201
JOURNAL ARTICLE

Cytarabine/daunorubicin

&NA;

Journal:   Reactions Weekly Year: 2010 Vol: &NA; (1294)Pages: 16-16
JOURNAL ARTICLE

Cytarabine/daunorubicin

Journal:   Reactions Weekly Year: 2015 Vol: 1545 (1)Pages: 84-84
JOURNAL ARTICLE

Cytarabine/daunorubicin

Journal:   Reactions Weekly Year: 2022 Vol: 1907 (1)Pages: 161-161
© 2026 ScienceGate Book Chapters — All rights reserved.